IL1RL1 and infection: Furthermore, inhibition of the ST2/IL-33 pathway and subsequent dampening of the downstream MyD88/MAPK/NF-κB inflammatory pathways may prevent the secretion of cytokines from immune cells, potentially impacting infection response [22].